Equity Investees (Tables)

12 Months Ended

Dec. 31, 2020

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Consolidated Financial Statements Related To Equity Investees

The following table presents information included in our Consolidated Financial Statements related to our equity investees.

	Year Ended December 31,
	2020		2019		2018
Genesis’ share of operating earnings	$	79,510	$	71,975	$	59,255
Amortization of differences attributable to Genesis' carrying value of equity investments	(15,491)		(15,491)		(15,629)
Net equity in earnings	$	64,019	$	56,484	$	43,626
Distributions received	$	81,061	$	77,331	$	71,714

Schedule of Balance Sheet Information For Equity Investees

The following tables present the combined balance sheet information for the last two years and income statement data for the last three years for our equity investees (on a 100% basis):

	December 31,
	2020		2019
BALANCE SHEET DATA:
Assets
Current assets	$	42,565	$	44,129
Fixed assets, net	299,315		321,752
Other assets	25,654		16,739
Total assets	$	367,534	$	382,620
Liabilities and equity
Current liabilities	$	13,411	$	20,081
Other liabilities	248,857		252,331
Equity	105,266		110,208
Total liabilities and equity	$	367,534	$	382,620

Schedule of Operations For Equity Investees

	Year Ended December 31,
	2020		2019		2018
INCOME STATEMENT DATA:
Revenues	$	214,687	$	209,674	$	180,056
Operating Income	$	153,640	$	155,920	$	129,160
Net Income	$	147,560	$	139,436	$	115,669